Head-To-Head Comparison: Salarius Pharmaceuticals (NASDAQ:SLRX) vs. Hepion Pharmaceuticals (NASDAQ:HEPA)
Institutional & Insider Ownership 17.2% of Hepion Pharmaceuticals shares are owned by institutional investors. Comparatively, 11.9% of Salarius Pharmaceuticals shares are owned by institutional investors. 4.7% of Hepion Pharmaceuticals shares are owned by insiders. Comparatively, 1.4% of Salarius Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and […]
Institutional & Insider Ownership 17.2% of Hepion Pharmaceuticals shares are owned by institutional investors. Comparatively, 11.9% of Salarius Pharmaceuticals shares are owned by institutional investors. 4.7% of Hepion Pharmaceuticals shares are owned by insiders. Comparatively, 1.4% of Salarius Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and […]
